Moclobemide

Moclobemide is an antidepressant drug of the reversible inhibitor of monoamine oxidase type A (RIMA) class. It is used to treat depression, social anxiety disorder and panic disorder. Moclobemide works by increasing the levels of serotonin and other neurotransmitters in the brain. It is generally well tolerated with few side effects. Common side effects include nausea, dizziness, dry mouth, headache, insomnia and constipation.

Moclobemide is a medication used primarily to treat depression and social anxiety disorder. Here's a breakdown of its key characteristics:

Function:

  • Moclobemide belongs to a class of drugs called reversible inhibitors of monoamine oxidase type A (RIMAs).
  • Monoamine oxidase A (MAOA) is an enzyme that breaks down certain chemicals in the brain, including serotonin, norepinephrine, and dopamine. These chemicals play a role in mood regulation.
  • By inhibiting MAOA, Moclobemide helps to increase the levels of these neurotransmitters in the brain, which can improve mood and reduce symptoms of depression and social anxiety.

Important Considerations:

  • Moclobemide is not as widely used as some other antidepressants due to a few key factors:
    • Dietary restrictions: Certain foods and beverages can interact dangerously with Moclobemide, so a strict diet is necessary while taking it.
    • Drug interactions: Moclobemide can interact with many other medications, so careful monitoring is crucial.
    • Potential for serious side effects: In rare cases, Moclobemide can cause a life-threatening condition called serotonin syndrome if taken with certain other medications or foods.

Applications:

  • Despite the limitations, Moclobemide can be an effective treatment option for depression and social anxiety, especially in cases where other medications haven't been successful.

Administration:

  • Moclobemide comes as tablets taken by mouth, usually once or twice daily.
Anatomical Therapeutic Chemical Classification
N - Nervous system
N06 Psychoanaleptics
N06A - Antidepressants
N06AG Monoamine oxidase A inhibitors
External Links